• Study on Gallium (68Ga) Tezatabep Matraxetan PET for Evaluating HER2 Status in Patients with Gastro-Esophageal and HER2-Low Breast Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Thiamine for Reducing Fatigue in Rheumatoid Arthritis Patients

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on the Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Drugs:
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on the Safety of Migalastat for Patients with Fabry Disease and Severe Kidney Problems on Dialysis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Portugal Spain

  • Study of Pembrolizumab, Carboplatin, and Cabazitaxel for Patients with Aggressive Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

  • Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain

  • Study on the Safety and Effectiveness of BCN-CP01 for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium The Netherlands Spain

  • Long-Term Study on the Safety of Avalotcagene Ontaparvovec for Adults with Late-Onset Ornithine Transcarbamylase Deficiency

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain

  • Study on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Germany Italy Poland Spain

powered by